Terapias Avanzadas para Tumores Sólidos Pediátricos
University Hospital of Lausanne
Lausana, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Lausanne (5)
2024
-
Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment
Methods in Cell Biology (Academic Press Inc.), pp. 79-97
2023
-
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53
2021
-
CD40 agonist targeted to fibroblast activation protein a synergizes with radiotherapy in murine HPV-positive head and neck tumors
Clinical Cancer Research, Vol. 27, Núm. 14, pp. 4054-4065
2020
-
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
Journal for immunotherapy of cancer, Vol. 8, Núm. 1
-
Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells
Frontiers in Immunology, Vol. 11